Search research articles
Contact Us
Filters
Showing results (161-170 of 314) with videos related to
Page
of 32
Sort By:
Drug Discovery Today
|
June 25, 2013
Molecular imaging in the development of a novel treatment paradigm for glioblastoma (GBM): an integrated multidisciplinary commentary
Monika A Jarzabek, Kieron J Sweeney, Rhys L Evans, et al.
Neuro-Oncology
|
October 20, 2024
Is modulation of immune checkpoints on glioblastoma-infiltrating myeloid cells a viable therapeutic strategy?
Ruochen Du, Jianzhong Zhang, Rimas V Lukas, et al.
Scientific Reports
|
October 21, 2015
Genome-wide DNA methylation detection by MethylCap-seq and Infinium HumanMethylation450 BeadChips: an independent large-scale comparison
Tim De Meyer, Pierre Bady, Geert Trooskens, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 6, 2018
<i>MGMT</i> Promoter Methylation Cutoff with Safety Margin for Selecting Glioblastoma Patients into Trials Omitting Temozolomide: A Pooled Analysis of Four Clinical Trials
Monika E Hegi, Els Genbrugge, Thierry Gorlia, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 23, 2014
Reply to M.C. Chamberlain
Mark R Gilbert, James Dignam, Stephanie Pugh, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
October 4, 2014
Efficacy of vinorelbine plus granulocyte colony-stimulation factor for CD34+ hematopoietic progenitor cell mobilization in patients with multiple myeloma
Panagiotis Samaras, Sarah Pfrommer, Burkhardt Seifert, et al.
Neuro-Oncology
|
June 1, 2010
Prolonged survival for patients with newly diagnosed, inoperable glioblastoma with 3-times daily ultrafractionated radiation therapy
Patrick Beauchesne, Valerie Bernier, Charlotte Carnin, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 26, 2010
An international validation study of the EORTC brain cancer module (EORTC QLQ-BN20) for assessing health-related quality of life and symptoms in brain cancer patients
Martin J B Taphoorn, Lily Claassens, Neil K Aaronson, et al.
Brain Pathology (Zurich, Switzerland)
|
April 11, 2008
Anti-O6-methylguanine-methyltransferase (MGMT) immunohistochemistry in glioblastoma multiforme: observer variability and lack of association with patient survival impede its use as clinical biomarker
Matthias Preusser, Robert Charles Janzer, Jörg Felsberg, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 25, 2012
A phase I dose-escalation study of the immunocytokine EMD 521873 (Selectikine) in patients with advanced solid tumours
Silke Gillessen, Ulrike S Gnad-Vogt, Elisa Gallerani, et al.
Page
of 32
Search research articles
Search
Showing results (161-170 of 314) with videos related to
Sort By:
Page
of 32
Drug Discovery Today
|
June 25, 2013
Molecular imaging in the development of a novel treatment paradigm for glioblastoma (GBM): an integrated multidisciplinary commentary
Monika A Jarzabek, Kieron J Sweeney, Rhys L Evans, et al.
Neuro-Oncology
|
October 20, 2024
Is modulation of immune checkpoints on glioblastoma-infiltrating myeloid cells a viable therapeutic strategy?
Ruochen Du, Jianzhong Zhang, Rimas V Lukas, et al.
Scientific Reports
|
October 21, 2015
Genome-wide DNA methylation detection by MethylCap-seq and Infinium HumanMethylation450 BeadChips: an independent large-scale comparison
Tim De Meyer, Pierre Bady, Geert Trooskens, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 6, 2018
<i>MGMT</i> Promoter Methylation Cutoff with Safety Margin for Selecting Glioblastoma Patients into Trials Omitting Temozolomide: A Pooled Analysis of Four Clinical Trials
Monika E Hegi, Els Genbrugge, Thierry Gorlia, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 23, 2014
Reply to M.C. Chamberlain
Mark R Gilbert, James Dignam, Stephanie Pugh, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
October 4, 2014
Efficacy of vinorelbine plus granulocyte colony-stimulation factor for CD34+ hematopoietic progenitor cell mobilization in patients with multiple myeloma
Panagiotis Samaras, Sarah Pfrommer, Burkhardt Seifert, et al.
Neuro-Oncology
|
June 1, 2010
Prolonged survival for patients with newly diagnosed, inoperable glioblastoma with 3-times daily ultrafractionated radiation therapy
Patrick Beauchesne, Valerie Bernier, Charlotte Carnin, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 26, 2010
An international validation study of the EORTC brain cancer module (EORTC QLQ-BN20) for assessing health-related quality of life and symptoms in brain cancer patients
Martin J B Taphoorn, Lily Claassens, Neil K Aaronson, et al.
Brain Pathology (Zurich, Switzerland)
|
April 11, 2008
Anti-O6-methylguanine-methyltransferase (MGMT) immunohistochemistry in glioblastoma multiforme: observer variability and lack of association with patient survival impede its use as clinical biomarker
Matthias Preusser, Robert Charles Janzer, Jörg Felsberg, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 25, 2012
A phase I dose-escalation study of the immunocytokine EMD 521873 (Selectikine) in patients with advanced solid tumours
Silke Gillessen, Ulrike S Gnad-Vogt, Elisa Gallerani, et al.
Page
of 32